Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - RLX030

  • Heart Failure Drug Reduces Mortality at Phase III
    Novartis' recombinant human relaxin-2 drug candidate RLX030 (serelaxin) reduced all-cause ... The study involved administering RLX030 to patients on admission to hospital in the form ...
    9-24-2012

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll